echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Lancet rheumatology: Humoral responses after second and third SARS-CoV-2 vaccination with immunosuppressive agents in patients with immune-mediated inflammatory diseases: a cohort study

    Lancet rheumatology: Humoral responses after second and third SARS-CoV-2 vaccination with immunosuppressive agents in patients with immune-mediated inflammatory diseases: a cohort study

    • Last Update: 2022-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    OBJECTIVE : Disease-specific studies report impaired humoral responses following SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with specific immunosuppressant.


    OBJECTIVE : A disease-specific study reported impaired humoral responses following SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with specific immunosuppressant.


    Methods : A cohort study was conducted among participants treated in outpatient clinics at seven university hospitals and a rheumatology treatment center in the Netherlands, as well as participants in two national cohort studies on COVID-19- related disease severit.


    Methods : A cohort study was conducted among participants treated in outpatient clinics at seven university hospitals and a rheumatology treatment center in the Netherlands , as well as participants in two national cohort studies on COVID-19- related disease severit.


    Results Results : Between February 2 and August 1 , 2021 , there were 3222 participants in the cohor.


    Conclusions Conclusions : The humoral response after vaccination is impaired by specific immunosuppressan.


    Source: Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort stu.


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.